Jubilant Pharmova (JUBLPHARMA) — Board Meeting

📢 Key Event
All resolutions passed at 48th AGM with high approval rates

🔄 What Changed
Dividend declared at ₹5 per share; new Director appointed

🔮 What's Next
Line 3 commercial production starting FY27; PET facilities operational from FY28

💡 Investor Takeaway
Dividend declaration signals confidence in FY26 profitability and cash flow stability

Jubilant Pharmova held its 48th AGM on August 26, 2026, via video conference, passing all resolutions with requisite majority. Remote e-voting occurred from August 23-25, 2026, with NSDL scrutiny confirming results. The filing details FY26 financials, including robust EBITDA margins across segments and [amount context mismatch] per share dividend declaration for FY26. Operational milestones include Line 3 commercial ramp-up in FY27 and expansion of radiopharmaceutical facilities. FY27 Q1 revenue reached [amount context mismatch] billion (17% YoY growth).

📄 View Original Announcement (PDF)

📊 Stock Analysis — JUBLPHARMA ✨ Ask AI About This

About Jubilant Pharmova Limited (JUBLPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹14,055.76 Cr P/E: 39.7 ROE: 5.0% ROCE: 7.4% Div Yield: 0.57%

View full JUBLPHARMA stock details →

📡 Get AI alerts when JUBLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JUBLPHARMA — Free

💡 Ask AI about this filing

"What is the expected dilution from the upcoming capital raise?" "How does CDMO margin expansion compare to peers like Dr. Reddy's?" "When will MIBG NDA be submitted after Phase 2 completion?"

Ask AI Free →

📊 More JUBLPHARMA filings

See all JUBLPHARMA filings →

🔥 Also filed on 26 August 2026

ORIENTCEM Orient Cement Limited Corporate Action IRB IRB Infrastructure Developers Limited Corporate Action EUROTEXIND Eurotex Industries and Exports Limited Annual Report INNOVISION Innovision Limited Announcement MOLDTECH Mold-Tek Technologies Limited Corporate Action MOTHERSON Samvardhana Motherson International Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JUBLPHARMA files new disclosures

Track JUBLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JUBLPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd